Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Biosyent Inc V.RX

Alternate Symbol(s):  BIOYF

BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing biologically and health friendly non-chemical insecticides. Its products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Maintenance 45, FeraMAX Pd Powder 15, Gelclair, Inofolic, Proktis-M, RepaGyn, and Tibella. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. Cathejell combines sterile gel and 2% lidocaine jelly in a collapsible syringe that is ready to use. FeraMAX Pd Therapeutic 150 is an oral hematinic that helps the body form red blood cells and is indicated for the treatment of iron deficiency anemia.


TSXV:RX - Post by User

Comment by Kadillacon Jun 25, 2020 12:29am
95 Views
Post# 31188979

RE:RE:RE:RE:RE:Hint at New Product Acquisition

RE:RE:RE:RE:RE:Hint at New Product Acquisition

This is what I found.  Maybe it was an acquisition of the product instead of in licensing. I have attached link on where below comes from.  

 

''The original polysaccharide-iron-complex (PIC) was from Schwartz Pharma, which developed, manufactured, and launched the first PIC under the brand name Niferex. Schwartz ultimately transferred its manufacturing rights of this PIC molecule to a third party and Niferex was subsequently discontinued in Canada.

BioSyent Pharma contracted the manufacturing exclusivity of this PIC molecule and then continued to manufacture the product under a new brand, namely FeraMAX®. Consequently, as it is derived directly from the original manufacturing process of PIC, FeraMAX® is the original PIC molecule.

Currently FeraMAX® is the only iron supplement manufactured in a North American FDA approved facility.

Subsequently, there have been several “Branded Generic” PICs launched in Canada trying to leverage the success of this formulation that provides less side effects and convenient once a day dosing.''

https://www.feramax.com/patient-information-2/faq/
 

<< Previous
Bullboard Posts
Next >>